Glenda Gray to HIV Antibodies
This is a "connection" page, showing publications Glenda Gray has written about HIV Antibodies.
Connection Strength
0,864
-
Reevaluating HIV vaccine clinical trials policy for infants. J Infect Dis. 2015 Feb 15; 211(4):501-3.
Score: 0,398
-
Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition. N Engl J Med. 2021 03 18; 384(11):1003-1014.
Score: 0,157
-
Immune correlates of the Thai RV144 HIV vaccine regimen in South Africa. Sci Transl Med. 2019 09 18; 11(510).
Score: 0,141
-
Subtype C gp140 Vaccine Boosts Immune Responses Primed by the South African AIDS Vaccine Initiative DNA-C2 and MVA-C HIV Vaccines after More than a 2-Year Gap. Clin Vaccine Immunol. 2016 06; 23(6):496-506.
Score: 0,112
-
Evaluation of the MUREX*ICE HIV-1.O.2 capture enzyme immunoassay for early identification of HIV-1 seroreverting infants in a developing country. Clin Diagn Virol. 1997 May; 8(1):1-8.
Score: 0,030
-
Determination of HIV Status in African Adults With Discordant HIV Rapid Tests. J Acquir Immune Defic Syndr. 2015 Aug 01; 69(4):430-8.
Score: 0,027